Clinical trial NCT04365530: Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City
Official title: Become of Patients Infected or Suspected of Being Infected by Covid-19 and Supported by the GHPSJ and the Establishments of the Paris Plaisance Hospital City
Study type: OBSERVATIONAL
Overall status: COMPLETED
Conditions: COVID
Lead sponsor: Fondation Hôpital Saint-Joseph
Sponsor class: OTHER
First posted: 2020-04-28
Enrollment: 3767
Sex: ALL
Standard ages: CHILD
ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Observational model: COHORT
Time perspective: OTHER
Sampling method: NON_PROBABILITY_SAMPLE
Study population: Patientwith symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.

Brief summary: The ongoing Coronavirus (Covid-19) pandemic is causing a major global health crisis and is shaking up hospital organizations. To date, the recognized risk factors for severe forms of Covid-19 infection are elderly patients (\> 70 years), obese patients, patients with chronic renal or respiratory pathologies, cardiovascular history (stroke or coronary artery disease), chronic respiratory conditions, high blood pressure, diabetes, and cancer. Covid-19 is manifested by a risk of acute respiratory distress syndrome requiring management by invasive ventilation. The lethality of this infection is around 4% in the current data.

Drastic precautionary measures for the transmission of the virus, as well as the provision of critical care beds by canceling any scheduled non-urgent intervention or consultation, have shaken up the hospital organization.

In this context, it is essential to have forward-looking data in real time to adjust the care offer and better understand the impact of Covid-19 on the patient populations treated.


Eligibility criteria: Inclusion Criteria:

- Patient (of all ages) with symptoms compatible with infection by Covid-19 treated at the GHPSJ or in one of the establishments in the Paris Plaisance hospital city.

Exclusion Criteria:

* Asymptomatic patient
* Patient objecting to the use of their data

Primary outcomes:
measure: Clinical consequences of a Covid-19 infection in the care population
timeFrame: Year 2
Secondary outcomes:
measure: Risk factors at M6
timeFrame: Month 6
measure: Risk factors at year 1
timeFrame: Year 1
measure: Risk factors at year 2
timeFrame: Year 2
measure: Impact of hospital reorganization on medical care at M6
timeFrame: Month 6
measure: Impact of hospital reorganization on medical care at Year 1
timeFrame: Year 1
measure: Impact of hospital reorganization on medical care at Year 2
timeFrame: Year 2
Other outcomes:
Locations:
city: Le Plessis-Robinson
country: France
facility: Hôpital Marie Lannelongue
city: Paris
country: France
facility: AURA Paris Plaisance
city: Paris
country: France
facility: Fondation Sainte-Marie
city: Paris
country: France
facility: Groupe Hospitalier Paris Saint-Joseph
city: Paris
country: France
facility: Hôpital Bellan
Study officials:
affiliation: Fondation Hôpital Saint-Joseph
name: Benoit PILMIS, MD
role: PRINCIPAL_INVESTIGATOR
References: